Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest & Investment Income (2020 - 2025)

RxSight (RXST) has disclosed Interest & Investment Income for 6 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 18.95% year-over-year to $2.2 million, compared with a TTM value of $9.3 million through Dec 2025, down 1.5%, and an annual FY2025 reading of $9.3 million, down 1.5% over the prior year.
  • Interest & Investment Income was $2.2 million for Q4 2025 at RxSight, down from $2.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.9 million in Q3 2024 and bottomed at $10000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $1.3 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income crashed 89.8% in 2021, then skyrocketed 8260.0% in 2022.
  • Year by year, Interest & Investment Income stood at $10000.0 in 2021, then surged by 8260.0% to $836000.0 in 2022, then skyrocketed by 98.68% to $1.7 million in 2023, then surged by 62.97% to $2.7 million in 2024, then fell by 18.95% to $2.2 million in 2025.
  • Business Quant data shows Interest & Investment Income for RXST at $2.2 million in Q4 2025, $2.4 million in Q3 2025, and $2.3 million in Q2 2025.